N-(4-Bromophenyl)butanamide is an organic compound characterized by its amide functional group, which consists of a butane chain attached to a phenyl ring that is substituted with a bromine atom at the para position. This compound typically exhibits a white to off-white crystalline appearance. Its molecular structure contributes to its physical and chemical properties, including moderate solubility in organic solvents and limited solubility in water due to the hydrophobic nature of the bromophenyl group. The presence of the bromine atom can influence the compound's reactivity, making it a potential candidate for various chemical reactions, including nucleophilic substitutions and coupling reactions. Additionally, the compound may exhibit biological activity, which could be of interest in pharmaceutical research. Safety data should be consulted for handling and storage, as halogenated compounds can pose health risks. Overall, N-(4-bromophenyl)butanamide serves as a valuable compound in organic synthesis and medicinal chemistry.

N-(4-BROMOPHENYL)BUTANAMIDE

N-(4-Bromophenyl)butanamide is a positron-emitting radiotracer that binds to the metabotropic glutamate receptor (mGluR), which has been implicated in the pathogenesis of neuropathic pain. It is used for imaging in positron emission tomography (PET) and single photon emission computed tomography (SPECT). The binding of this drug to mGluR can be seen by PET imaging, which provides a measureable and quantifiable measurement of mGluR density. N-(4-Bromophenyl)butanamide can be used as an alternative to non-metabolized, radioactive compounds such as 11C-labelled 2-deoxyglucose for mapping changes in glucose metabolism. This drug may also have potential for use in humans as a treatment for psychiatric disorders, such as schizophrenia.

CAS 119199-11-0: N-(4-BROMOPHENYL)BUTANAMIDE

N-(4-Bromophenyl)butanamide

Ref: 3D-UEA19911

Butanamide, N-(4-bromophenyl)-

Ref: IN-DA000IBO

N-(4-Bromophenyl)butanamide

Ref: 10-F080304